Preslow 50 mg (Tablet)
Unit Price: ৳ 8.02 (5 x 10: ৳ 401.00)
Strip Price: ৳ 80.20
Medicine Details
Category | Details |
---|---|
Generic | Losartan potassium |
Company | Labaid pharma ltd |
Also available as |
Indications
- Hypertension
- Renal Protection in Type-2 Diabetic Patients with Proteinuria
Pharmacology
Losartan Potassium is the first non-peptide orally active angiotensin II receptor blocker.
Dosage & Administration
- Usual starting and maintenance dose of 50 mg once daily for most patients
- 25 mg twice daily recommended prior to increasing the dose for inadequate antihypertensive effect
- lower starting dose of 25 mg once daily recommended for patients over 75 years
- Total daily dose ranges from 25 mg to 100 mg
Interaction
- Rifampicin and fluconazole reduce levels of active metabolite of Preslow
- Concomitant use of Preslow and hydrochlorothiazide may lead to potentiation of the antihypertensive effects
- Concomitant use of potassium-sparing diuretics, potassium supplements or salt substitutes containing potassium may lead to increases in serum potassium
- The antihypertensive effect of losartan may be attenuated by the non-steroidal anti-inflammatory drug indomethacin
- The use of ACE-inhibitor, angiotensin receptor antagonist, an anti-inflammatory drug and a thiazide diuretic at the same time increases the risk of renal impairment
Contraindications
- Pregnant women
- Patients hypersensitive to any component of this product
- Patients with diabetes taking Aliskiren
Side Effects
- Dizziness
- Diarrhea
- Nasal congestion
- Cough
- Upper respiratory infection
- Fatigue
- Oedema
- Abdominal pain
- Chest pain
- Nausea
- Headache
- Pharyngitis
Pregnancy & Lactation
Pregnancy Category D.
Precautions & Warnings
- Avoid use during the second and third trimesters of pregnancy
- Symptomatic hypotension may occur in volume-depleted patients
- Significantly increased plasma concentration in cirrhotic patients
- Changes in renal function including renal failure reported in renal impaired patient
Use in Special Populations
- No initial dosage adjustment necessary in patients with mild renal impairment
- Lower starting dose recommended for moderate to severe renal impairment or patients on dialysis
- Lower dose should be considered for patients with a history of hepatic impairment
Therapeutic Class
Angiotensin-ll receptor blocker
Storage Conditions
Dry place away from light and heat. Keep out of the reach of children.